From Lab Test to Recurring Care

Diving deeper into

Superpower

Company Report
This approach captures value across the entire health optimization journey rather than just the initial diagnostic phase.
Analyzed 4 sources

Superpower is trying to turn a one time lab purchase into a recurring health spend wallet. The blood panel gets the customer in the door, but the bigger business is what happens after results arrive, when members book clinician consults, buy follow up tests, order supplements or prescription compounds, and keep messaging the care team inside the same app. That makes the product closer to a digital longevity clinic than a testing subscription.

  • The workflow is built to keep spending inside one system. Members book blood draws, see 100 plus biomarkers in a dashboard, get body system scores, ask the AI chat questions, meet clinicians, then receive protocols tied to a marketplace for supplements, prescriptions, and more testing.
  • That is the main difference versus Function Health. Function built a large business on a simpler $499 annual testing subscription with limited doctor involvement, while Superpower adds messaging, consults, wearables data, and commerce layers that can raise revenue per member after the initial panel.
  • A closer economic analog is Hone Health, where diagnostics are the front end of a much larger recurring treatment relationship. Hone converts testing into monthly subscriptions plus medication add ons, which shows how much more value can be captured when the company owns the follow up workflow, not just the test result.

The market is moving from standalone biomarker reports toward full stack health management. Superpower’s path from here is to deepen that loop, with more condition specific protocols, more employer distribution, and more products sold against each member record, so the lab test becomes the start of a longer care and commerce relationship.